Provided by Tiger Trade Technology Pte. Ltd.

Carlsmed, Inc.

14.27
+0.51003.71%
Post-market: 14.500.2300+1.61%16:29 EDT
Volume:151.59K
Turnover:2.16M
Market Cap:388.60M
PE:-10.69
High:14.61
Open:13.97
Low:13.70
Close:13.76
52wk High:17.23
52wk Low:8.50
Shares:27.23M
Float Shares:15.67M
Volume Ratio:1.95
T/O Rate:0.97%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3350
EPS(LYR):-2.1247
ROE:-66.14%
ROA:-28.19%
PB:4.61
PE(LYR):-6.72

Loading ...

Carlsmed Price Target Raised to $20.00/Share from $18.00 by Truist Securities

Dow Jones
·
Aug 07

Establishment Labs Q2 Revenue Rises, Beats Estimates

Reuters
·
Aug 06

Teleflex Q2 Revenue Rises 29%, Beats Analyst Estimates

Reuters
·
Aug 06

Truist Adjusts Price Target on Carlsmed to $20 From $18, Maintains Buy Rating

MT Newswires Live
·
Aug 06

Carlsmed, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 06

Carlsmed Q2 Net Loss Widens 55.3% to $10.51 Million; Revenue Rises 57% to $18.9 Million

Reuters
·
Aug 06

Carlsmed Q2 EPS $(0.39) Beats $(0.41) Estimate, Sales $18.940M Beat $17.948M Estimate

Benzinga Earnings
·
Aug 06

Carlsmed Inc Q2 Gross Margin 76.8%

THOMSON REUTERS
·
Aug 06

Carlsmed Inc Q2 Adjusted Ebitda USD -8.6 Million

THOMSON REUTERS
·
Aug 06

Carlsmed® Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance

THOMSON REUTERS
·
Aug 06

Press Release: Carlsmed(R) Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance

Dow Jones
·
Aug 06

Carlsmed, Inc. Expected to Post a Loss of 41 Cents a Share - Earnings Preview

Reuters
·
Aug 04

Carlsmed - Announces CMS Finalizes Favorable Reimbursement for Aprevo Lumbar Procedures in Fy2027

THOMSON REUTERS
·
Aug 03

Carlsmed - New MS-Drg Assignments and Payment Rates Effective October 1, 2026

THOMSON REUTERS
·
Aug 03

Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures

GlobeNewswire
·
Aug 03

Carlsmed to Join Bank of America SMID Cap Virtual Conference Fireside Chat

Reuters
·
Jul 28

Carlsmed, Inc. To Participate in Upcoming Investor Conferences

GlobeNewswire
·
Jul 28

Carlsmed to Report Q2 2026 Results After Market Close, Host Conference Call

Reuters
·
Jul 23

Carlsmed Initiated at Buy by Needham

Dow Jones
·
Jul 01

Needham Initiates Carlsmed at Buy With $17 Price Target

MT Newswires Live
·
Jul 01